Patent · US Active

Anti-TMPRSS6 antibodies and uses thereof

US12215170B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 5, 2021
Grant dateFeb 4, 2025
Priority date
Expiry dateNov 5, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Antibodies and antigen-binding fragments thereof that bind type II transmembrane serine protease 6 (TMPRSS6) on the surface of a cell and increase hepcidin expression, and methods for treating disorders of iron metabolism using anti TMPRSS6 antibodies and fragments, are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.